News UK starts 'world-first' gonorrhoea vaccination push The UK has started a gonorrhoea vaccination programme designed to prevent thousands of infections and save the NHS millions of pounds.
News Moderna cuts staff amid operating 'uncertainty' Moderna will cut another 10% of its workforce as it tries to trim $1.5 billion off its annual costs by 2027.
News Sanofi to buy UK vaccines developer Vicebio for $1.6bn Sanofi has agreed to buy UK start-up Vicebio, set up to produce improved, more potent shots that are simpler to manufacture, for $1.15bn upfront.
News US measles elimination status at risk as cases soar Measles cases are roaring back in the US, with nearly 1,300 cases so far this year, 25 years after the disease was declared eliminated by the CDC.
News Barriers are limiting UK childhood vaccination, say doctors Vaccination rates for children are declining in the UK, but it's not just because of vaccine hesitancy.
News Moderna shines spotlight on new flu vaccine data Moderna may be facing regulatory uncertainty in the US for its vaccine pipeline, but at least its clinical data is hitting the right notes.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.